FDA Approves New Cancer Medication
The US Food and Drug Administration (FDA) approved Zydelig (idelalisib) today to treat patients with three types of blood cancers.
Hodgkin Lymphoma Treatment May Boost Breast Cancer Risks
The vast majority of children who develop Hodgkin lymphoma beat the blood cancer after treatment, which includes powerful radiation. A new study looked at how that therapy affected young patients later in life.
Non-Hodgkin Lymphoma Rx Reduced Tumors
A new type of medication that disables lymphoma tumor cells has shown considerable success for patients who were not responding to other treatments.
Boosting Blood Cancer Survival
Lymphomas are blood cancers that start in the cells of the immune system. Burkitt’s lymphoma is a particularly aggressive form of the disease. New research may have discovered a better way to treat it.
New Rx for Blood Cancer Approved
Mantle cell lymphoma is a rare, but aggressive form of blood cancer. It’s a form of non-Hodgkin lymphoma. Patients with this disease got a new treatment option today.
Treating Blood Cancer During Pregnancy
Pregnancy is such an exciting time in a woman’s life. She’s caring for herself and the child growing inside her. Sometimes, but not often, this bliss is interrupted with a cancer diagnosis. A recent study looked at treating blood cancers during pregnancy.
Stem Cell Transplants for Non-Hodgkin Lymphoma
Non-Hodgkin lymphoma is a term that covers various types of blood cancers that develop in the lymphatic system. Researchers recently set out to see if replacing these cancerous cells with healthy ones could help improve survival.
What Cancer Patients Aren’t Talking About
During your doctor visits, there are some things you may not want to bring up. You may think they’re concerns your doctor can't help you with, or maybe you’re embarrassed to talk about them. Recent research looked at what topics cancer patients are willing to discuss with their doctors.
Wait, I Didn’t Know That About Blood Cancer!
Since there is no screening test for blood cancers, early detection is a challenge. But advances in blood cancer treatments are helping patients live longer, more fulfilling lives.
The Long and Winding Cancer Road
Treatments for cancers afflicting young people have improved vastly over the years. For example, survival rates have never been higher for Hodgkin lymphoma, one of the most common cancers in young adults.